Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
Clinical trial NCT03199846 · COMPLETED
Trial details
- NCT number
- NCT03199846
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-10-25
- Primary completion
- 2017-10-30
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.